Tuesday, May 29, 2018

Great Quotes, the Conscious Capitalism Edition: How Teddy Roosevelt Wanted to Spend His Days

For this�Rule Breaker Investing podcast, host David Gardner once again climbs up onto the shoulders of giants with a "Great Quotes" episode. These five memorable bon mots offer him excellent entries into topics that Foolish investors ought to be considering. Specifically, because May is Conscious Capitalism Month, he focused on wise words that can apply to that evolving holistic business philosophy.

In this segment, he offers us a simple but profound idea from President Theodore Roosevelt on the topic of work.

A full transcript follows the video.

This video was recorded on May 16, 2018.

David Gardner: Great Quote No. 2 comes from Teddy Roosevelt. I'm a big T.R. fan. I know I'm speaking to a lot of others. I hope you've enjoyed Candice Millard's wonderful book, The River of Doubt, which tells the remarkable story of Teddy Roosevelt's voyage into South America trying to find the source of a mysterious and very dangerous river after he was president in his 50s. A remarkable story. Candice has been on this podcast. We talked a little bit about The River of Doubt. I'm looking forward to her next book, which will be about finding the source of the Nile. That's a few years hence, but excited about that.

Teddy Roosevelt -- here's what he said. "Far and away the best prize that life offers is the chance to work hard at work worth doing."

Now, I don't know what that spawns for you, but that spawns two thoughts for me. The first is that I want that for my life and I hope you want that for your life. I want that for your life. "Far and away the best prize that life offers is the chance to work hard at work worth doing."

It's often been pointed out that not all of America's workforce is highly engaged. My brother Tom has a fun way of putting this. He said, "If we're all in a canoe together paddling, and we have 10 of us, and we're each representing one-tenth of the American workforce, there are three people in the front paddling hard forward. 30% of America's workforce is engaged and excited and passionate about its work. The five people sitting behind them in the canoe are not paddling at all. They're just along for the ride. And then, unfortunately, there are one or two people in the back who are actively disengaged. That is, they're hostile to their own organization and, if you will, paddling backward."

Now, just imagine how much faster our canoes could move if all of us, or at least the majority of us, were paddling forward, and if you're visualizing at least five people paddling forward and nobody paddling backward, you're starting to see the kinds of companies that we invest in as Rule Breakers, because we're looking into the hearts of the companies of the stocks that we pick, and we're looking for places that people want to work and feel great about the work that [they're] doing.

So, thought No. 1 spawned by Theodore Roosevelt. I sure hope that's true of your work, and if it's not, I would encourage you to make whatever changes you can as rapidly as possible to get into a place where the work that you're doing is worth doing and you want to work hard at it because selfishly, I'm going to be a lot better off if that's true of you, just like you will of me, because we're co-creating value together and, in fact, we're paying taxes together. We're only paying taxes out of profits and salaries if we're employed. Everything is better, worldwide, when people have found the right work for them.

And then the second thought about that quote goes right back to the heart of Rule Breaker Investing. We're looking for companies that are doing important things in this world. The stocks that I'm picking -- the ones that we talk about in our five-stock samplers on this podcast -- if you're a stock market investor [and I sure hope you are], I hope some of these companies are in your portfolio. Think about what the work is worth doing and make sure your dollars are there.

Sometimes I've said, "Looking backward over the last 25 years are you able to say the big trends of my time -- the zeitgeists, the spirit of my age -- I had my money in those companies." Were you, let's say, 25 years ago invested in America Online, the decade that America came online? It was an amazing stock for quite a while there.

Or more recently as the whole world has shifted toward the internet, have you been invested in Netflix? And let's not even look backwards. How about going forwards? Do you think this is a company that's going to get bigger and add more and more value to the world over the next 20 years? I sure do think so. This should be true of as many of the companies as you look down your brokerage statement as possible. Ask, "Are they working hard at work worth doing?"

Genomics. Curing cancer. Making your home smarter. Artificial intelligence making the products and services around us better and better. Is this work worth doing and are you invested in it? I sure hope you are.

Saturday, May 26, 2018

Top 5 Low Price Stocks To Own Right Now

tags:AHT,KN,QSII,ECL,TGA, �Q: The stock market seems to be reaching new record highs every day. Are there any stocks that still look cheap?

Corporate earnings have exhibited pretty impressive growth as a whole over the past few years, so the market's performance is somewhat justified. However, many stocks do look to be rather expensive right now -- particularly in the tech sector. Yet some bargains remain.

One of my favorite "cheap" stocks right now is AT&T (NYSE: T), even after shares popped following the company's strong quarterly report. The telecom giant pays a dividend yielding more than 5% and is a Dividend Aristocrat, meaning that it has increased its dividend for more than 25 consecutive years.

Despite a low price-to-earnings multiple of just 13 times 2017's expected earnings, AT&T has lots of room to grow, especially thanks to its purchase of DIRECTV and its pending acquisition of Time Warner, both of which should give it an advantage over the competition when it comes to bundling services and broadcasting content directly to smartphones and tablets.

Top 5 Low Price Stocks To Own Right Now: Ashford Hospitality Trust Inc(AHT)

Advisors' Opinion:
  • [By Logan Wallace]

    Ashtead Group (LON:AHT) insider Wayne Edmunds bought 14,260 shares of the stock in a transaction that occurred on Thursday, May 3rd. The shares were bought at an average price of GBX 2,059 ($28.72) per share, for a total transaction of 拢293,613.40 ($409,502.65).

Top 5 Low Price Stocks To Own Right Now: Knowles Corporation(KN)

Advisors' Opinion:
  • [By Stephan Byrd]

    Sony (NYSE: SNE) and Knowles (NYSE:KN) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

  • [By Lisa Levin]

    Shares of Knowles Corporation (NYSE: KN) got a boost, shooting up 15 percent to $12.83 as the company reported Q1 results.

    SVB Financial Group (NASDAQ: SIVB) shares were also up, gaining 19 percent to $305.90 following strong quarterly results.

  • [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8. Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica. DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance. eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results. Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results. SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results. Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results. Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday. ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday. Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Joseph Griffin]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get Knowles alerts: Head to Head Contrast: Knowles (KN) vs. Sony (SNE) (americanbankingnews.com) Knowles (KN) Given Consensus Rating of “Hold” by Analysts (americanbankingnews.com) Four seniors nab scholarships from Siouxland Officials Association (siouxcityjournal.com) When is Who Dares Wins on BBC One tonight, how old is host Nick Knowles and how does the game show work? (thesun.co.uk) Local students learn the art of architecture (dailytidings.com)

    KN has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $17.00 price target (down from $20.00) on shares of Knowles in a research report on Thursday, February 8th. Zacks Investment Research lowered Knowles from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th. ValuEngine lowered Knowles from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. JPMorgan Chase lowered their price target on Knowles from $16.00 to $13.50 and set a “neutral” rating for the company in a research report on Tuesday, April 24th. Finally, Lake Street Capital lowered their price target on Knowles from $19.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, February 8th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $17.29.

Top 5 Low Price Stocks To Own Right Now: Quality Systems, Inc.(QSII)

Advisors' Opinion:
  • [By Dan Caplinger]

    The stock market finished the week on a quiet note, with most major benchmarks closing slightly lower on the day. Investors went into the weekend trying to navigate a series of geopolitical and macroeconomic issues, but many market participants focused on the big plunge in the oil market, where crude prices dropped $3 per barrel to fall below the $68-per-barrel mark. Even with trading activity slow preceding the holiday weekend, good news sent shares of some companies higher. Roku (NASDAQ:ROKU), Shoe Carnival (NASDAQ:SCVL), and Quality Systems (NASDAQ:QSII) were among the best performers on the day. Here's why they did so well.

  • [By Timothy Green]

    Shares of Quality Systems Inc. (NASDAQ:QSII) jumped on Friday following the company's fiscal fourth-quarter report. The provider of software and services to the healthcare industry beat analyst estimates on all fronts. The stock was up 13% at market close.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion. Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million. Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion. Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million. Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million. Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million. Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million. Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million. DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion. 8x8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million. Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million. ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion. Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion. Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million. Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million. Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue
  • [By Lisa Levin]

    Shares of Quality Systems, Inc. (NASDAQ: QSII) got a boost, shooting up 14 percent to $17.08 after the company posted better-than-expected FQ4 results.

  • [By Shane Hupp]

    Quality Systems (NASDAQ:QSII) shares saw unusually-strong trading volume on Friday following a stronger than expected earnings report. Approximately 2,338,700 shares changed hands during mid-day trading, an increase of 593% from the previous session’s volume of 337,438 shares.The stock last traded at $16.99 and had previously closed at $15.05.

  • [By Lisa Levin] Gainers Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares surged 20.6 percent to $6.39. WBB Securities upgraded Melinta Therapeutics from Hold to Speculative Buy. Shoe Carnival, Inc. (NASDAQ: SCVL) shares climbed 17.2 percent to $30.87 after the company reported upbeat quarterly earnings. Acorn International, Inc. (NYSE: ATV) shares rose 15.2 percent to $28.804 after the company declared a special one-time cash dividend of $14.97 per ADS. Foot Locker, Inc. (NYSE: FL) gained 15 percent to $53.35 after the company reported better-than-expected results for its first quarter. Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) surged 14.2 percent to $2.625. ArQule, Inc. (NASDAQ: ARQL) rose 13 percent to $5.12 after gaining 4.86 percent on Thursday. Quality Systems, Inc. (NASDAQ: QSII) gained 12.8 percent to $16.97 after the company posted better-than-expected FQ4 results. Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE: LOMA) shares rose 12 percent to $12.94. ArQule, Inc. (NASDAQ: ARQL) shares rose 12 percent to $5.07. Mirati Therapeutics, Inc. (NASDAQ: MRTX) climbed 11.4 percent to $43.50. Zai Lab Limited (NASDAQ: ZLAB) gained 11.3 percent to $24.7000. Zymeworks Inc. (NASDAQ: ZYME) rose 9.7 percent to $19.64. Park City Group, Inc. (NASDAQ: PCYG) climbed 9 percent to $7.90. Roku, Inc. (NASDAQ: ROKU) gained 7.9 percent to $38.82 after Citron reversed previously bearish position on the stock. Sears Holdings Corporation (NASDAQ: SHLD) shares jumped 7.3 percent to $3.55. Deckers Outdoor Corp (NYSE: DECK) rose 3.5 percent to $107.27 after reporting better-than-expected results for its fiscal fourth quarter.

    Check out these big penny stock gainers and losers

Top 5 Low Price Stocks To Own Right Now: Ecolab Inc.(ECL)

Advisors' Opinion:
  • [By ]

    Ecolab (ECL) : "That's a terrific situation that I want you to buy more of if it comes down."

    PTC (PTC) : "Not my cup of tea but I understand it's in the sweet spot of tech."

  • [By ]

    3. Ecolab (NYSE: ECL)
    This water, hygiene, and energy services company is being heavily bought by Bill Gates. Mr. Gates has purchased around a million shares across several transactions in the last 30 days. His purchase price was between $134.00 and $137.00 per share.

  • [By ]

    In the Lightning Round, Cramer was bullish on Goldman Sachs (GS) , Berkshire Hathaway (BRK.B) , Ecolab (ECL) , PTC (PTC) , Arista Networks (ANET) , U.S. Concrete (USCR) and Masco (MAS) .

Top 5 Low Price Stocks To Own Right Now: Transglobe Energy Corp(TGA)

Advisors' Opinion:
  • [By Max Byerly]

    Atlas Energy Group (OTCMKTS: ATLS) and Transglobe Energy (NASDAQ:TGA) are both small-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

  • [By Lisa Levin] Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California. AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32. Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65. Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System. VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495. TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61. Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities. Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39. MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock. FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956. TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38. 21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41. NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32. Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy. LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported. Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight. Energizer Holdings, Inc. (NYSE:
  • [By Lisa Levin] Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California. AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93. TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday. Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55. VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39. Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49. Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday. Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01. MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock. TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43. World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program. Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90. NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director. Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday. Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results. 21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34. Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de

Friday, May 25, 2018

Best Value Stocks For 2018

tags:BSRR,BPT,UUUU,AIMT,AEGN,

If�Vipshop Holdings (NYSE:VIPS)�investors are feeling jittery these days, it's because they know that earnings season is here. The Chinese online discounter of brand-name apparel reports its first-quarter results after the market close on Monday, and it's been known to treat longs and shorts to some pretty wild swings. Vipshop will host its earnings call on Tuesday morning ahead of the market open.

The dot-com speedster is expected to check in with another quarter of hearty double-digit percentage growth on the top line. Analysts see revenue rising 22.4% to $3.08 billion. It's a different story on the bottom line, where analysts see earnings per share declining to $0.18 after scoring a profit of $0.21 a year earlier.�

Image source: Vipshop Holdings.

Watch me move

Vipshop has had no shortage of ups and downs. The stock more than doubled for three consecutive years, from 2012 to 2014 -- something you rarely see -- only to lose nearly half its value in the two years that followed. The stock bounced back slightly in 2017. Vipshop has gone on to trounce the market averages in 2018, but it's now declining for the third month in a row.�

Best Value Stocks For 2018: Sierra Bancorp(BSRR)

Advisors' Opinion:
  • [By Ethan Ryder]

    O Shaughnessy Asset Management LLC trimmed its position in Sierra Bancorp (NASDAQ:BSRR) by 41.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,173 shares of the financial services provider’s stock after selling 7,846 shares during the quarter. O Shaughnessy Asset Management LLC owned 0.07% of Sierra Bancorp worth $298,000 at the end of the most recent reporting period.

Best Value Stocks For 2018: BP Prudhoe Bay Royalty Trust(BPT)

Advisors' Opinion:
  • [By Dan Caplinger]

    The stock market had a tumultuous session on Wednesday, as major benchmarks started the day weak but bounced back in the afternoon. Investors weren't happy with the current state of geopolitical uncertainty, with trade disputes threatening to become larger problems than ever. But the release of the minutes of the latest meeting of the Federal Reserve's monetary policy committee convinced many that the central bank will be slow to do lasting damage to the economic expansion, remaining measured in the pace of its interest rate increases. Moreover, some companies had good news that sent their shares higher. Tiffany (NYSE:TIF), BP Prudhoe Bay Royalty Trust (NYSE:BPT), and Ralph Lauren (NYSE:RL) were among the best performers on the day. Here's why they did so well.

  • [By Joseph Griffin]

    News headlines about BP Prudhoe Bay Royalty Trust (NYSE:BPT) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. BP Prudhoe Bay Royalty Trust earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave media headlines about the oil and gas company an impact score of 46.2072909143413 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Best Value Stocks For 2018: Energy Fuels Inc(UUUU)

Advisors' Opinion:
  • [By Stephan Byrd]

    Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) shares saw an uptick in trading volume on Monday . 1,091,365 shares were traded during mid-day trading, an increase of 300% from the previous session’s volume of 272,846 shares.The stock last traded at $2.09 and had previously closed at $2.04.

Best Value Stocks For 2018: Aimmune Therapeutics, Inc.(AIMT)

Advisors' Opinion:
  • [By ]

    In the Lightning Round, Cramer was bullish on Ingersoll-Rand (IR) , The Blackstone Group (BX) , Thermo Fisher Scientific (TMO) , FMC Corp (FMC) , Nike (NKE) , Zebra Technologies (ZBRA) and Aimmune Therapeutics (AIMT) .

  • [By Chris Lange]

    Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.13, with a consensus price target of $55.50 and a 52-week range of $15.97 to $40.65.

  • [By ]

    Aimmune Therapeutics (AIMT) : "I do like it. That's an important niche business. "

    Ingersoll-Rand (IR) : "I like Ingersoll-Rand. They work well at this phase in the cycle."

Best Value Stocks For 2018: Aegion Corp(AEGN)

Advisors' Opinion:
  • [By Shane Hupp]

    LSV Asset Management decreased its position in Aegion Corp (NASDAQ:AEGN) by 5.7% in the 1st quarter, HoldingsChannel reports. The fund owned 108,700 shares of the construction company’s stock after selling 6,600 shares during the period. LSV Asset Management’s holdings in Aegion were worth $2,490,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    Aegion (NASDAQ:AEGN) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Wednesday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aegion (AEGN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Thursday, May 24, 2018

Toll Brothers: Buying This Bear, And The D.R. Horton Bear, Too

Toll enters bear market - on little news

Toll Brothers (TOL), a large home builder that is unique in that it specializes in luxury homes, has entered a bear market, off to $39.46 from a Jan. 22 high of $52. The drop from nearly $44 came on a measly 4 cent per share miss from expectations in its Q2 EPS. However, per ETrade, Q1 results, reported in February, beat expectations by much more, $0.21. Why the miss? The company's two main explanations were a $12 MM writedown of a struggling, older development in Connecticut, and slippage in closing 15 homes in California; these homes will close in the current, fiscal third quarter. Also, some condos in NYC had to be discounted, but apparently were still sold profitably; but this is a totally non-core part of TOL's business. Finally, some noted cancellations up a bit; but they are at a low level.

For all that, the analysts were almost ludicrous in their concern about SG&A above 10%. The company assured them that it will come down, but these things happen in luxury home building.

More important, the present looks bright based on the order book; TOL projects SG&A to decline despite increased expenses for 75 new selling communities planned to open by the end of October; and it reports it has not seen an adverse effect from rising rates.

So why were analysts so hesitant, to some extent even nervous Nellies, on the conference call, and why was the stock destroyed? And why did a stalwart such as D.R. Horton (DHI), and the most home builder-focused ETF (ITB), sell off in sympathy?

Some thoughts on these matters follow.

Home, sweet home; why are the builders not so sweet?

Actually, some have been, including TOL, over the long haul.

Since going public in 1986, TOL has returned almost 13% per year, but with unpredictable choppiness:

Chart TOL data by YCharts

Looking at the data, it appears that the S&P 500 has returned about 7.7% per year since the same time in price, thus no more than 10% in total return counting dividends.

This is how my two favorite builders, TOL and DHI, have fared versus the ETF for the S&P 500 (SPY), since 1993:

Chart DHI data by YCharts

DHI has been great, but as discussed later, right now I find TOL more attractive.

The bursting of the housing bubble destroyed many weaker players. That both TOL and DHI have done well versus the SPY since the 2003-4 time frame may speak well to their resiliency. But psyches have been harmed, and no investor has to own these stocks. That's likely one reason why there is so little support for TOL, along with the predictable short selling.

The above are major reasons why I'm getting more interested in having more dollars exposed here, i.e. beginning to reverse the risk-off tactics I adopted in late January. The point of having a lot of cash on the sidelines is to deploy it.

The next section demonstrates my preferred way of thinking of TOL, DHI, home builders, and other value stocks in today's market. It's not the only relevant way to think about things, but it could explain a lot of how certain stocks trade these days.

The tech bubble-housing analogy

The Y2K period, really beginning in 1998, is important to my thesis, because something similar looks to be going on now.

The average stock peaked at the end of 1997, then had a very weak 1998. In contrast, the average tech/NASDAQ stock, and members of the SPY in general and favored non-tech large cap growth in particular, were strong. It was the bubble phenomenon, and by 2000, you can see how the red line (the SPY) moved far ahead of TOL and DHI. But, home sales did OK; so did prices. Yet Old Economy stocks, notably housing stocks in my observation, were depressed. By 1999 and 2000, I had a mantra about the alleged wisdom of the mythical Mr. Market. That mantra was, if "he" was really so filled with foreknowledge of the future, then the future of middle-class (and richer) Americans was to live in hovels surrounded by vast amounts of electronic gear. Tech was it!

But it soon wasn't. Soon, tech was a wreck. Hot one year, hated the next.

What was "it" in tech's place?

Yes - homes. Condos in sand states. Instead of double or triple ordering of semiconductor and other components for electronic gizmos, by 2005, there were the equivalent of double and triple ordering of ordinary homes/condos in ordinary (or less than ordinary) places.

The tech bubble was in essence repeated with the housing bubble.

Now fast forward to the Great Recession and its aftermath. Tech held up relatively well in the GR, but lingering worries about the economy and about tech made stalwarts such as Apple (AAPL) and Microsoft (MSFT) trade below 10X EPS in the 2010-2 period. But, look at them, and tech stocks (QQQ) now.

So: from the 1998-2000 peaking of the QQQ, it took over 10 years for tech to get hot again, more like 12-14 depending where you start from and when you think they did more than just rebound from the GR.

When did housing stocks peak? 2005.

We are now 13 years on. Just as MSFT and AAPL were silly cheap after the summer 2011 sell-off, and then again perhaps in 2012 (I haven't gone back to check the precise dates), many housing stocks are crazy cheap relative to the market (my tech bubble analogy again).

Now for some numbers to put meat on those bones.

Leading housing stocks versus the SPY

Since you don't have to be Einstein to say that in investing, it's all relative, what matters most is the value of one asset versus another. Cash versus an equity versus a debt instrument, etc. In this case, let's say the SPY versus TOL. While TOL is not dirt cheap on objective standards, it's very cheap relative to the SPY.

Per the SPDRs web site, the SPY is shown at 21X TTM EPS. Whether that is adjusted numbers or GAAP, I'm not sure. TOL closed Tuesday at $39.46. Using ETrade data, I calculate TTM GAAP EPS of $3.69 for TOL. That's a 10.7X P/E.

The SPDR is at a forward P/E of about 17.4X. As of Wednesday, ETrade is showing FY consensus EPS for TOL of $4.46. The more precise comparator to 2018 earnings for the SPY would be projected EPS for TOL through the January 2019 quarter. This is lower, at $4.32. (Note, though, that FY 2019 consensus is higher than for 2018, at $4.86.)

At about 9X calendar 2018 EPS, TOL offers investors an approximate 11% earnings yield (reciprocal of the P/E). As discussed in the next section, this opens up potentially easy strategies to drive greater shareholder value even though the Street is not supporting TOL at this time.

The multiples for DHI, an easier company to analyze than TOL, are a little higher than for TOL, but in the same deep discount ballpark, and with steadier growth projected for DHI as well.

So, what justifies such deep discounts, now that you know that over the past 25-32 years, DHI and TOL have beaten the market?

Little but fear in my humble opinion.

And, there is a catalyst for TOL, a little-known one that might turn it into a durable and more consistent winner for a change.

The NVR example

Sorry for a third chart, but here's an exceptional stock chart of NVR (NVR), a large home builder, versus the outperformer DHI:

Chart DHI data by YCharts

Yes, it's real. The secret: great cash management, in two spheres.

NVR optioned rather than bought its land, thus saving its cash, and did little to no spec building. Then, when most of the time the stock was at a huge P/E discount to the market, it retired as many shares as it could. NVR's operations have been fine, but the stock has done what it has done from a massively cash-efficient operational and financial engineering strategy. And the result is that NVR now trades at 19X TTM EPS and at around a $3000 share price, about 13.3X projected 2019 EPS of $225 per share. But projected sales growth is lower than projected for both TOL and DHI through 2019. Some of the premium P/E probably relates to NVR's financial strength, but I don't see all that much difference, so I think a lot of the valuation premium comes from its established record of growth. (Yet a premium P/E makes the benefit of buybacks to NVR less compelling now, especially compared to TOL's opportunity.)

TOL is going toward the NVR model: optioning more land, finding ways to put up less cash on some of its deals, and doing substantial buybacks. So: quality of cash utilization over quantity. If successful, this could finally lead to TOL's stock outperforming the business, as has occurred for NVR.

That it is doing well operationally led to the CFO sounding frustrated and emphatic about TOL's progress on the conference call (just my opinion).

This is why I like TOL more than DHI now, though I bought some DHI as well as more TOL on the crash Tuesday. If TOL is trading at 8-9X 2018-9 earnings (no guarantees), there could be a small pot of gold to investors now that the stock price has dropped so much.

Risks

As noted, no one has to own a housing stock, which is a cyclical beast that has no glamour and little support on the Street. Fed tightening and recession can do a company great harm, and this can be the case even for leaders such as TOL and DHI.

Concluding comments - TOL for the long run

In the Trump era, I believe I first mentioned TOL on November 25, 2016, in Markets Think 'MAGA' - So, Buying Builders; Focus On Toll Brothers. The stock was $30 then, so it has had a little more than a 30% total return in 1 1/2 years, still fine, and the stock is now quite cheap to the SPY. I am not foreseeing a 2019-20 recession that the Street to a significant degree does expect, so that's one reason for yours truly to hang tough with a cyclical stock. Another reason is that going back to the 1999-2000 period where we had Cisco (CSCO) and Yahoo! (now Altaba (AABA)) instead of Amazon (AMZN), Netflix (NFLX) and Tesla (TSLA) today, TOL and other home builders can move up in a recessionary bear market period:

TOL bottomed in February 2000 at a split-adjusted $4 per share. By the time the SPY bottomed in or around October 2002, TOL was at $9.

Something similar could happen again.

As you can see, this article is focused on TOL's stock, and is not a review of the quarter, which you are welcome to explore for yourself. TOL has diversified its business lines, and is geographically diverse as well. If you are interested in TOL but are unfamiliar with it, some investment of time will be required to understand its story in detail. (DHI is simpler; so is NVR.)

I am long TOL and DHI somewhat for trading gains but more for a reversion upward toward the mean for home building as a percentage of GDP in the United States, and very possibly eventually, as with tech now, to a level above the mean. Thus my major goal with these stocks is long term capital appreciation, understanding that the risks are not trivial and patience likely will be required.

Thanks for reading and sharing any comments you wish to contribute.

Disclosure: I am/we are long TOL,DHI,AAPL,MSFT.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: Not investment advice. I am not an investment adviser.

Wednesday, May 23, 2018

What to Expect When Hewlett Packard Enterprise Reports After the Close

Hewlett Packard Enterprise Co. (NYSE: HPE) is scheduled to release its fiscal second-quarter financial results after the markets close on Tuesday. Thomson Reuters has consensus estimates of $0.31 in earnings per share (EPS) on $7.38 billion in revenue. In the same period of last year, HPE said it had EPS of $0.35 and $7.45 billion in revenue.

Following HPE��s most recent earnings report, Merrill Lynch issued an Underperform rating with a $14 price objective.

The firm detailed its investment rationale as follows:

Our Underperform rating is based on 1) headwinds facing the server business from Tier-1 customers moving increasingly to lower-cost alternatives, 2) competitive pricing pressure, 3) reduced growth in Storage (ex 3PAR all flash which continues to show strong growth), 4) continued headwind from commodity costs (including DRAM), and 5) free cash flow still below historical levels on one-time payments related to restructuring, separation costs, tax payments, etc.

Merrill Lynch seems to be half right as the stock has dropped about 2.5% since that earnings report. However, over the past 52 weeks, HPE has outperformed the broad markets with its stock up about 22%. And in the past six months, the stock is up about 32%.

A few analysts weighed in on HPE ahead of the upcoming report:

OTR Global has a Positive rating. JPMorgan has a Neutral rating. UBS has a Neutral rating with a $19 price target. BMO Capital Markets has a Market Perform rating with a $19 price target. Deutsche Bank has a Buy rating with a $22 price target.

Shares of HPE were last seen trading at $17.62, with a consensus analyst price target of $19.13 and a 52-week range of $12.70 to $19.48.

ALSO READ: Why This Higher Guidance Looks Even Better for Micron

Tuesday, May 22, 2018

Buy South Indian Bank; target of Rs 40: Prabhudas Lilladher


Prabhudas Lilladher's research report on South Indian Bank


SIB earnings were below estimates with PAT of Rs1.14bn (PLe: Rs1.24bn) on weaker operating performance. Bank's slippages were higher at Rs6.14bn than expected due to implementation of RBIs rules on treatment of restructured assets. These� were� majorly from corporate and 50% from the restructured book, but asset quality deterioration was contained on sale of NPA to ARC. Management has guided much lower slippages and credit cost going forward, while continue to be positive on delivering strong loan growth & steady NIMs.


Outlook


Lower PCR of ~41% can be of risk to higher provisions but some recoveries & lower slippages can help improve PCR. Retain BUY with TP of Rs40 based on 1.4x Mar-20E ABV.


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More

Sunday, May 20, 2018

Trexquant Investment LP Grows Position in Domtar Corp (UFS)

Trexquant Investment LP increased its position in shares of Domtar Corp (NYSE:UFS) (TSE:UFS) by 46.6% in the 1st quarter, Holdings Channel reports. The firm owned 13,077 shares of the basic materials company’s stock after purchasing an additional 4,157 shares during the quarter. Trexquant Investment LP’s holdings in Domtar were worth $556,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in UFS. Schwab Charles Investment Management Inc. lifted its holdings in Domtar by 7.3% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 309,945 shares of the basic materials company’s stock worth $15,349,000 after purchasing an additional 21,117 shares during the last quarter. Acadian Asset Management LLC lifted its holdings in Domtar by 644.5% during the 4th quarter. Acadian Asset Management LLC now owns 371,502 shares of the basic materials company’s stock worth $18,397,000 after purchasing an additional 321,603 shares during the last quarter. Oakbrook Investments LLC acquired a new stake in Domtar during the 4th quarter worth approximately $243,000. Ingalls & Snyder LLC acquired a new stake in Domtar during the 4th quarter worth approximately $485,000. Finally, Regentatlantic Capital LLC acquired a new stake in Domtar during the 4th quarter worth approximately $315,000. 95.25% of the stock is owned by institutional investors and hedge funds.

Get Domtar alerts:

Shares of NYSE UFS opened at $46.82 on Friday. The firm has a market capitalization of $2.95 billion, a price-to-earnings ratio of 18.01, a P/E/G ratio of 2.86 and a beta of 1.64. The company has a quick ratio of 1.26, a current ratio of 2.34 and a debt-to-equity ratio of 0.44. Domtar Corp has a fifty-two week low of $35.72 and a fifty-two week high of $52.58.

Domtar (NYSE:UFS) (TSE:UFS) last announced its quarterly earnings data on Tuesday, May 1st. The basic materials company reported $0.87 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.76 by $0.11. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Domtar had a positive return on equity of 7.45% and a negative net margin of 3.42%. The company’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.32 EPS. equities research analysts forecast that Domtar Corp will post 3.28 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 16th. Shareholders of record on Tuesday, July 3rd will be issued a $0.435 dividend. The ex-dividend date of this dividend is Monday, July 2nd. This represents a $1.74 annualized dividend and a yield of 3.72%. Domtar’s dividend payout ratio is presently 66.92%.

In other news, insider Michael Fagan sold 23,674 shares of the business’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $44.87, for a total transaction of $1,062,252.38. Following the completion of the transaction, the insider now owns 19,477 shares of the company’s stock, valued at approximately $873,932.99. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO John David Williams sold 68,556 shares of the business’s stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $45.28, for a total value of $3,104,215.68. Following the transaction, the chief executive officer now directly owns 55,242 shares of the company’s stock, valued at approximately $2,501,357.76. The disclosure for this sale can be found here. Insiders sold a total of 187,590 shares of company stock valued at $8,567,118 over the last ninety days. Insiders own 0.95% of the company’s stock.

Several analysts recently weighed in on the company. Scotiabank reissued a “sector perform” rating and set a $43.00 price target on shares of Domtar in a report on Wednesday, May 2nd. TheStreet raised Domtar from a “c” rating to a “b-” rating in a report on Tuesday, May 1st. Zacks Investment Research raised Domtar from a “hold” rating to a “buy” rating and set a $49.00 price target for the company in a report on Tuesday, May 1st. National Bank Financial lifted their price target on Domtar from $42.00 to $45.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 2nd. Finally, ValuEngine cut Domtar from a “strong-buy” rating to a “buy” rating in a report on Wednesday, May 2nd. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and six have assigned a buy rating to the stock. Domtar has a consensus rating of “Hold” and an average price target of $44.25.

Domtar Profile

Domtar Corporation designs, manufactures, markets, and distributes various communication papers, specialty and packaging papers, and absorbent hygiene products in the United States, Canada, Europe, Asia, and internationally. It operates in two segments, Pulp and Paper, and Personal Care. The company offers business papers, including copy and electronic imaging papers for use with inkjet and laser printers, photocopiers, and plain-paper fax machines, as well as computer papers, preprinted forms, and digital papers for office and home use.

Want to see what other hedge funds are holding UFS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Domtar Corp (NYSE:UFS) (TSE:UFS).

Institutional Ownership by Quarter for Domtar (NYSE:UFS)

Saturday, May 19, 2018

Lucky Seven: Exelixis Bounces Back, Global Blood Therapeutics Bleeds

Lucky Seven

The Lucky Seven is a swing-trading biotechnology portfolio of seven stocks listed in a way to reflect top picks and risk tolerance. The first three picks are the top picks (in no particular order). Risks are increased the further away a stock sits from #4 (the least risky stock).

1. Immune Design (IMDZ)

Price: 3.80/Gain 11.8%/Day 6

Immune Design crossed the 15% threshold on May 16, intraday. Therefore, it is a "win". We are continuing to hold based on (1) conviction of data, (2) insider confidence, and (3) technical indicators. While we saw shares in Immune Design take a breather after the intraday high on the 16th, we feel there's still room for additional appreciation:

Chart courtesy of StockTA.com

2. Viking Therapeutics (VKTX)

Price: 4.58/Gain 13.6%/Day 3

In addition to an Immune Design win, Viking rose over 15% intraday, May 17, for a win. Indicators are bullish in the near-term. A push over 5.40 may not see any additional resistance until 6.90 based on its prior movements. Note: It's likely that Madrigal (MDGL) data will be released next week.

Chart courtesy of StockTA.com

3. Array BioPharma (ARRY)

Price: 13.75/Gain 14.5%/Day 13

While Array already reached the 15% threshold, I believe it can hit the 30% threshold within a month or two. We will continue to hold.

4. Exelixis (EXEL)

Price: 21.77/Loss 0.8%/Day 14

Exelixis has made up nearly all of its losses after disappointing phase 3 data for its far less prominent and profitable cancer drug. We believe now is a great time to hold shares in Exelixis, as the $20.43 mark has served as massive support in the past (see chart below). Now appears to be a great opportunity to ride Exelixis' next phase of growth going forward.

Chart courtesy of StockTA.com

5. Achaogen (AKAO)

Price: 12.58/Loss 1%/Day 6

Shares of Achaogen closed at 12.45 on Friday. 12.40 has served as great support in the past. If Achaogen closes under 12.40, consider it sold for a loss at EOD price. It's probable shares will hang around the 12.40 support for a while before making a definitive move weeks from now.

Chart courtesy of StockTA.com

6. ChemoCentryx (CCXI)

Price: 11.45/Gain 7.3%/Day 3

ChemoCentryx appears to be the most encouraging chart, technically-wise, for near-term appreciation:

Chart courtesy of StockCharts.com

7. Global Blood Therapeutics (NASDAQ:GBT)

Price: 44.75/Gain 3%/Day 13

As predicted, shares in Global Blood bled late into last week. We are holding based on our conviction of phase 3 data.

I often utilize a presentation by BIO Industry Analysis that provides in-depth statistics on clinical development success rates from 2006-2015. It puts things in perspective. Some voxelotor-related points:

Hematology drugs have the highest probability of phase 2 and 3 success, compared to all other disease areas, with 57% and 75% success rates, respectively. Although common and chronic, SCD is actually considered an orphan/rare indication. Rare diseases have a higher probability of phase 3 success compared to chronic, high prevalence ones (73% vs. 58%). A downside: voxelotor is a new molecular entity. Such drugs have significantly greater difficulty in advancing through phases and earning a thumbs-up from regulators. However, FDA's decision to "back" voxelotor is likely to diminish the power of this statistic.

Considering the FDA has already peeked at data from Part A of the phase 3 HOPE study and was, apparently, favorable towards it, the likelihood of phase 3 success and subsequent NDA approval is very high. I think it's more than reasonable to assign an 80%+ chance of phase 3 success in adults and a 65%+ chance of phase 2 pediatric success.

Investing in biotechnology must be based on reason and odds and not of emotion. Although it is not guaranteed to be a successful trade, we are placing our bet on it based upon sound reasoning and odds. With those odds, more time than not, we will win and that will be made evident over time.

It's also of note that the "bleeding" last week was accompanied with low volume. Shares of Global Blood are not trading in a strange way:

Chart courtesy of StockCharts.com

This two-year chart demonstrates that although Global Blood sees legs up, it usually crouches its way back to its 200-day moving average. Positive phase 3 part A data will almost certainly send the stock to new highs that will again probably make its way back to its 200-day MA with time.

Lucky Seven Scorecard

Record: 4-1-3; Gain: 11.4% (theoretical - if we sold at 15%)

Loss/Synlogic, Inc. (SYBX)/sold 5/8/18, -1.6%/3 days

Win/Omeros Corp. (OMER)/sold 5/11/18, 34.5%/8 days

Gain/Viking Therapeutics (VKTX)/sold 5/11/18, 5.8%/8 days

Win/Array BioPharma (ARRY)/reached threshold 5/14/18, 15%/9 days

Gain/NovoCure (NVCR)/sold 5/15/18, 4.9%/10 days

Gain/Avid Bioservices (CDMO)/sold 5/15/18, 2.2%/8 days

Win/Immune Design (IMDZ)/reached threshold 5/16/18, 15%/4 days

Win/Viking Therapeutics (VKTX)/reached threshold 5/17/18, 15%/1 day

Author's note: For further insight into biotechnology stocks, please follow Clover Biotech Research.

Disclaimer: The intention of this article is to provide insight, not investment advice. One must consider one's own financial standings, risk tolerance, research, etc. before making a decision to buy shares in a company. Many of my articles detail biotechnology companies with little or no revenue. These stocks are, therefore, speculative and volatile. Even when prospects seem promising, there is no predicting the future. Losses incurred may be significant.

Disclosure: I am/we are long VKTX, GBT, IMDZ, CWBR.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.